| JYHB2100179 | 布地奈德吸入气雾剂 | budesonide | Aerosol | Chemical Drugs | Supplementary Application | 2021-03-05 | 凯西医药咨询（上海）有限公司 | Casey Medical Consulting (Shanghai) Co Ltd;Chiesi Farmaceutici SpA | Certificate Issued | 2022-01-25 | view |
| CYHS2000278 | 吸入用布地奈德混悬液 | budesonide | Inhalation | Chemical Drugs(4) | Generic Drug | 2020-04-27 | 四川普锐特药业有限公司 | Sichuan Purity Pharmaceutical Co Ltd | Certificate Issued | 2021-04-20 | view |
| JYHL2100001 | 布地奈德福莫特罗吸入粉雾剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(5.2) | Import Drug Application | 2021-02-11 | | Orion Corporation | In Review | 2021-02-11 | view |
| JYHL2100003 | 布地奈德福莫特罗吸入粉雾剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(5.2) | Import Drug Application | 2021-02-11 | | Orion Corporation | In Review | 2021-02-11 | view |
| JYHL2100002 | 布地奈德福莫特罗吸入粉雾剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(5.2) | Import Drug Application | 2021-02-11 | | Orion Corporation | In Review | 2021-02-11 | view |
| JXHS1900173 | 布地奈德福莫特罗吸入粉雾剂(II) | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(5.1) | Import Drug Application | 2020-01-08 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | Certificate Issued | 2021-01-21 | view |
| JXHS1900174 | 布地奈德福莫特罗吸入粉雾剂(II) | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(5.1) | Import Drug Application | 2020-01-08 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | Certificate Issued | 2021-01-21 | view |
| JYHB2002523 | 布地奈德鼻喷雾剂 | budesonide | Spray | Chemical Drugs | Supplementary Application | 2020-12-09 | 台湾海默尼药业有限公司 | Taiwan Hemony Pharmaceutical Co Ltd;Synmosa Biopharma Corporation Synmosa Plant | Filed | 2020-12-22 | view |
| CYHS1900131 | 布地奈德吸入混悬液 | budesonide | Inhalation | Chemical Drugs(4) | Generic Drug | 2019-02-18 | 深圳太太药业有限公司 | ShenZhen Taitai Pharmaceutical Industry Co Ltd;Joincare Pharmaceutical Group Industry Co Ltd | Certificate Issued | 2020-12-16 | view |
| JYHZ2000271 | 布地奈德福莫特罗吸入粉雾剂（II） | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | License Renew | 2020-12-14 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | In Review | 2020-12-12 | view |
| JYHB2002465 | 布地奈德鼻喷雾剂 | budesonide | Spray | Chemical Drugs | Supplementary Application | 2020-12-02 | McNeil Sweden AB | McNeil Sweden AB;McNeil AB | In Review | 2020-12-02 | view |
| JYHB2002464 | 布地奈德鼻喷雾剂 | budesonide | Spray | Chemical Drugs | Supplementary Application | 2020-12-02 | McNeil Sweden AB | McNeil Sweden AB;McNeil AB | In Review | 2020-12-02 | view |
| JYHB2002463 | 布地奈德鼻喷雾剂 | budesonide | Spray | Chemical Drugs | Supplementary Application | 2020-12-02 | McNeil Sweden AB | McNeil Sweden AB;McNeil AB | In Review | 2020-12-02 | view |
| JYHB2002462 | 布地奈德鼻喷雾剂 | budesonide | Spray | Chemical Drugs | Supplementary Application | 2020-12-02 | McNeil Sweden AB | McNeil Sweden AB;McNeil AB | In Review | 2020-12-02 | view |
| JYHB2002039 | 布地奈德鼻喷雾剂 | budesonide | Spray | Chemical Drugs | Supplementary Application | 2020-10-16 | 台湾海默尼药业有限公司 | Taiwan Hemony Pharmaceutical Co Ltd;Synmosa Biopharma Corporation Synmosa Plant | Filed | 2020-11-05 | view |
| JYHB2002046 | 布地奈德鼻喷雾剂 | budesonide | Spray | Chemical Drugs | Supplementary Application | 2020-10-16 | 台湾海默尼药业有限公司 | Taiwan Hemony Pharmaceutical Co Ltd;Synmosa Biopharma Corporation Synmosa Plant | Filed | 2020-11-05 | view |
| JXHL2000270 | 布地奈德富马酸福莫特罗吸入气雾剂 | budesonide;formoterol fumarate | Aerosol | Chemical Drugs(2.2) | Import Drug Application | 2020-09-29 | AstraZeneca AB | AstraZeneca AB | In Review | 2020-09-28 | view |
| JXHL2000269 | 布地奈德富马酸福莫特罗吸入气雾剂 | budesonide;formoterol fumarate | Aerosol | Chemical Drugs(2.2) | Import Drug Application | 2020-09-29 | AstraZeneca AB | AstraZeneca AB | In Review | 2020-09-28 | view |
| JYHB2001342 | 吸入用布地奈德混悬液 | budesonide | Inhalation | Chemical Drugs | Supplementary Application | 2020-08-21 | AstraZeneca Pty Ltd | Astrazeneca Pty Ltd | Filed | 2020-09-09 | view |
| JYHB2001341 | 吸入用布地奈德混悬液 | budesonide | Inhalation | Chemical Drugs | Supplementary Application | 2020-08-21 | AstraZeneca Pty Ltd | Astrazeneca Pty Ltd | Filed | 2020-09-09 | view |
